The site of Infogene makes use of Cookies so that you can have the best user experience for all the functionalities, without collection of any personal info. By continuing you do accept our privacy policy.
continue

Innovation at the
service of healthcare

Tailored solutions for
early cancer detection

Infogene has highly qualified technical staff in genetics, molecular virology and oncology, with more than 15 years of experience in cancer molecular research, and is focused on researching, developing, manufacturing and marketing new tests and services for early cancer detection through non-invasive methods.

Our laboratory uses the most advanced technologies for molecular diagnosis, such as polymerase chain reaction (PCR), quantitative real-time PCR (qPCR), digital PCR, DNA arrays and DNA sequencing.

Our Products

We currently have two innovative products. O Teste da Mulher includes a kit for vaginal fluid collection or self-collection for subsequent detection of high oncogenic risk human papillomaviruses (HPV), which are the main cause of cervical cancer. The Oncoalert is a test performed on a blood sample that can give you a warning signal and be the first step in the early detection of colorectal cancer.

Our Services

Innovation

Infogene strives to master all the competencies required to go through the innovation cycle for the development of products in the field of medical devices for in vitro diagnosis with application in cancer screening, from conception to product launch onto the market. To this end, we have developed relevant expertise in areas such as technical design and prototyping, industrial property and regulatory issues, preparation of technical documentation for conformity assessment, CE labeling and wholesale distribution of medical devices.

Want to Know More?
Contact us!